in the us , the aids Drug Assistance Program ( adap ), which used to cover the drug costs of 80,000 aids patients not covered by Medicaid or other private health insurances, is facing a hard time. This is because the budget for the fiscal year ending in October would fall short by an estimated $380 million, while there has been a 77 per cent increase in the number of clients. Another reason for this shortfall is the new combination therapies which, though effective, are far more expensive at keeping the hiv virus in check than the previous modes of treatments. About 50 state adap programmes are facing steep rises in both costs and caseload. In the past year, 34 states have limited their programmes to stretch funding -- restricting access to new drugs like protease inhibitors, or capping the number of people allowed in the programme.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.